van Laarhoven HWM - Search Results

1

Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis.

Pape M, Veen LM, Smit TM, Kuijper SC, Vissers PAJ, Geijsen ED, van Rossum PSN, Sprangers MAG, Derks S, Verhoeven RHA, van Laarhoven HWM. Pape M, et al. Among authors: van laarhoven hwm, van rossum psn. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):31-44. doi: 10.1016/j.ijrobp.2023.05.025. Epub 2023 May 22. Int J Radiat Oncol Biol Phys. 2023. PMID: 37224927 Review.

2

The life in sight application study (LISA): design of a randomized controlled trial to assess the role of an assisted structured reflection on life events and ultimate life goals to improve quality of life of cancer patients.

Kruizinga R, Scherer-Rath M, Schilderman JB, Sprangers MA, Van Laarhoven HW. Kruizinga R, et al. BMC Cancer. 2013 Jul 26;13:360. doi: 10.1186/1471-2407-13-360. BMC Cancer. 2013. PMID: 23889978 Free PMC article. Clinical Trial.

3

Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update.

Sprangers MA, Thong MS, Bartels M, Barsevick A, Ordoñana J, Shi Q, Wang XS, Klepstad P, Wierenga EA, Singh JA, Sloan JA; GeneQol Consortium. Sprangers MA, et al. Qual Life Res. 2014 Sep;23(7):1997-2013. doi: 10.1007/s11136-014-0656-1. Epub 2014 Mar 7. Qual Life Res. 2014. PMID: 24604075 Free PMC article. Review.

4

Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern.

Versteijne E, van Laarhoven HW, van Hooft JE, van Os RM, Geijsen ED, van Berge Henegouwen MI, Hulshof MC. Versteijne E, et al. Dis Esophagus. 2015 Jul;28(5):453-9. doi: 10.1111/dote.12215. Epub 2014 Apr 11. Dis Esophagus. 2015. PMID: 24725186

5

Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study.

Kordes S, van Berge Henegouwen MI, Hulshof MC, Bergman JJ, van der Vliet HJ, Kapiteijn E, van Laarhoven HW, Richel DJ, Klinkenbijl JH, Meijer SL, Wilmink JW. Kordes S, et al. Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):190-6. doi: 10.1016/j.ijrobp.2014.05.022. Int J Radiat Oncol Biol Phys. 2014. PMID: 25195993 Clinical Trial.

6

Reduction of heart volume during neoadjuvant chemoradiation in patients with resectable esophageal cancer.

Haj Mohammad N, Kamphuis M, Hulshof MC, Lutkenhaus LJ, Gisbertz SS, Bergman JJ, de Bruin-Bon HA, Geijsen ED, Bel A, Boekholdt SM, van Laarhoven HW. Haj Mohammad N, et al. Radiother Oncol. 2015 Jan;114(1):91-5. doi: 10.1016/j.radonc.2014.12.005. Epub 2015 Jan 24. Radiother Oncol. 2015. PMID: 25630429

7

Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent.

Haj Mohammad N, Walter AW, van Oijen MG, Hulshof MC, Bergman JJ, Anderegg MC, van Berge Henegouwen MI, Henselmans I, Sprangers MA, van Laarhoven HW. Haj Mohammad N, et al. Support Care Cancer. 2015 Dec;23(12):3589-98. doi: 10.1007/s00520-015-2727-4. Epub 2015 Apr 18. Support Care Cancer. 2015. PMID: 25894882 Free PMC article.

8

The effect of spiritual interventions addressing existential themes using a narrative approach on quality of life of cancer patients: a systematic review and meta-analysis.

Kruizinga R, Hartog ID, Jacobs M, Daams JG, Scherer-Rath M, Schilderman JB, Sprangers MA, Van Laarhoven HW. Kruizinga R, et al. Psychooncology. 2016 Mar;25(3):253-65. doi: 10.1002/pon.3910. Epub 2015 Aug 10. Psychooncology. 2016. PMID: 26257308 Review.

9

Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy.

Machiels M, Wouterse SJ, Geijsen ED, van Os RM, Bennink RJ, van Laarhoven HW, Hulshof MC. Machiels M, et al. J Med Imaging Radiat Oncol. 2016 Aug;60(4):520-7. doi: 10.1111/1754-9485.12474. Epub 2016 May 20. J Med Imaging Radiat Oncol. 2016. PMID: 27197751

10

Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.

Jeene PM, Versteijne E, van Berge Henegouwen MI, Bergmann JJ, Geijsen ED, Muller K, van Laarhoven HW, Hulshof MC. Jeene PM, et al. Dis Esophagus. 2017 Feb 1;30(2):1-5. doi: 10.1111/dote.12539. Dis Esophagus. 2017. PMID: 27766725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

518 results

Search Page